SynsoryBio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $275K

  • Investors
  • 8

SynsoryBio General Information

Description

Operator of a biotechnology research company intended to develop conditionally active therapeutics. The company uses proprietary technology to create next-generation therapeutics and potent drugs for diseases including cancer and autoimmune disorders, enabling patients to access treatments for these conditions.

Contact Information

Website
www.synsorybio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 75 Kneeland Street
  • 14th floor
  • Boston, MA 02111
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 75 Kneeland Street
  • 14th floor
  • Boston, MA 02111
  • United States

SynsoryBio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynsoryBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 11-Jul-2024 $275K Completed Startup
5. Early Stage VC 01-Jul-2024 Completed Startup
4. Seed Round 01-Mar-2024 Completed Startup
3. Accelerator/Incubator 01-Jan-2024 Completed Startup
2. Accelerator/Incubator 10-Sep-2023 $10K $10K Completed Startup
1. Accelerator/Incubator 01-Jan-2023 Completed Startup
To view SynsoryBio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

SynsoryBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SynsoryBio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
US National Science Foundation Accelerator/Incubator
Axial (San Francisco) Venture Capital Minority
Gurtin Ventures Venture Capital Minority
Phoenix Investment Club (San Francisco) Venture Capital Minority
Unpopular Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

SynsoryBio FAQs

  • When was SynsoryBio founded?

    SynsoryBio was founded in 2023.

  • Where is SynsoryBio headquartered?

    SynsoryBio is headquartered in Boston, MA.

  • What is the size of SynsoryBio?

    SynsoryBio has 2 total employees.

  • What industry is SynsoryBio in?

    SynsoryBio’s primary industry is Drug Discovery.

  • Is SynsoryBio a private or public company?

    SynsoryBio is a Private company.

  • What is SynsoryBio’s current revenue?

    The current revenue for SynsoryBio is .

  • How much funding has SynsoryBio raised over time?

    SynsoryBio has raised $1.75M.

  • Who are SynsoryBio’s investors?

    US National Science Foundation, Axial (San Francisco), Gurtin Ventures, Phoenix Investment Club (San Francisco), and Unpopular Ventures are 5 of 8 investors who have invested in SynsoryBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process